Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 20, 2011 - Issue 5
Submit an article Journal homepage
298
Views
4
CrossRef citations to date
0
Altmetric
Drug Evaluations

Aromatase inhibition: a potential target for the management of recurrent or metastatic endometrial cancer by letrozole: more questions than answers?

Helen L Steed Cross Cancer Institute, Department of Gynecological Oncology, Edmonton, AB, Canada; University of Alberta, Department of Obstetrics and Gynecology, Edmonton, AB, Canada
&
Quincy S-C Chu Cross Cancer Institute, Department of Medical Oncology, 11560 University Avenue, Edmonton, AB T6G 1Z2, Canada [email protected]; University of Alberta, Department of Oncology, Edmonton, AB, Canada
Pages 681-690 | Published online: 18 Mar 2011

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.